NVAX CIK: 1000694

Novavax Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
1.15
FY22:
1.08
FY23:
0.64
FY24:
0.48
FY25:
1.05
(positive)
Change from FY21 to FY25
billions USD
FY21:
−1.69
FY22:
−0.64
FY23:
−0.57
FY24:
−0.25
FY25:
0.45
(positive)
billions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−0.16
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
−1.71
FY22:
−0.65
FY23:
−0.54
FY24:
−0.18
FY25:
0.44
(positive)
Change from FY21 to FY25
billions USD
FY21:
−1.74
FY22:
−0.66
FY23:
−0.55
FY24:
−0.19
FY25:
0.44

All amounts in billions USD Data sources:SEC EDGARTwelve Data